{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T16:42:38Z","timestamp":1773679358836,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T00:00:00Z","timestamp":1543190400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003176","name":"Ministerio de Educaci\u00f3n, Cultura y Deporte","doi-asserted-by":"publisher","award":["FIS PI13 01293"],"award-info":[{"award-number":["FIS PI13 01293"]}],"id":[{"id":"10.13039\/501100003176","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007801","name":"Fundaci\u00f3n S\u00e9neca","doi-asserted-by":"publisher","award":["19540\/PI\/14"],"award-info":[{"award-number":["19540\/PI\/14"]}],"id":[{"id":"10.13039\/100007801","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011199","name":"FP7 Ideas: European Research Council","doi-asserted-by":"publisher","award":["115009"],"award-info":[{"award-number":["115009"]}],"id":[{"id":"10.13039\/100011199","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12974-018-1357-4","type":"journal-article","created":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T03:24:34Z","timestamp":1543202674000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Effect of NAC treatment and physical activity on neuroinflammation in subchronic Parkinsonism; is physical activity essential?"],"prefix":"10.1186","volume":"15","author":[{"given":"Ana-Luisa","family":"Gil-Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorena","family":"Cuenca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Consuelo","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Estrada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emiliano","family":"Fern\u00e1ndez-Villalba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Trinidad","family":"Herrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,26]]},"reference":[{"issue":"9996","key":"1357_CR1","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE. Parkinson\u2019s disease. Lancet. 2015;386(9996):896\u2013912.","journal-title":"Lancet"},{"issue":"1\u20132","key":"1357_CR2","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/0304-3940(94)91094-4","volume":"175","author":"I P\u00e9rez-Ota\u00f1o","year":"1994","unstructured":"P\u00e9rez-Ota\u00f1o I, Oset C, Luquin MR, Herrero MT, Obeso JA, Del R\u00edo J. MPTP-induced parkinsonism in primates: pattern of striatal dopamine loss following acute and chronic administration. Neurosci Lett. 1994;175(1\u20132):121\u20135.","journal-title":"Neurosci Lett"},{"key":"1357_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnana.2014.00155","volume":"8","author":"J Blesa","year":"2014","unstructured":"Blesa J, Przedborski S. Parkinson\u2019s disease: animal models and dopaminergic cell vulnerability. Front Neuroanat. 2014;8:1\u201312.","journal-title":"Front Neuroanat"},{"issue":"10","key":"1357_CR4","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1111\/cns.12727","volume":"23","author":"B-D Li","year":"2017","unstructured":"Li B-D, Bi Z-Y, Liu J-F, Si W-J, Shi Q-Q, Xue L-P, et al. Adverse effects produced by different drugs used in the treatment of Parkinson\u2019s disease: a mixed treatment comparison. CNS Neurosci Ther. 2017;23(10):827\u201342.","journal-title":"CNS Neurosci Ther"},{"issue":"3","key":"1357_CR5","first-page":"231","volume":"3","author":"P Brundin","year":"2015","unstructured":"Brundin P, Barker RA, Conn PJ, Dawson TM, Kieburtz K. Linked clinical trials \u2013 the development of new clinical learning studies in Parkinson\u2019s disease using screening of multiple prospective new treatments. J Park Dis. 2015;3(3):231\u20139.","journal-title":"J Park Dis"},{"key":"1357_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.brainresbull.2016.03.012","volume":"125","author":"LJ Spielman","year":"2016","unstructured":"Spielman LJ, Little JP, Klegeris A. Physical activity and exercise attenuate neuroinflammation in neurological diseases. Brain Res Bull. 2016;125:19\u201329.","journal-title":"Brain Res Bull"},{"key":"1357_CR7","volume-title":"Health topics","author":"World Health Organization","year":"2018","unstructured":"World Health Organization. Health topics 2018 [Internet]. [cited 2018 Mar 29]. Available from: \n                    http:\/\/www.who.int\/topics\/physical_activity\/en\/\n                    \n                  ."},{"issue":"4","key":"1357_CR8","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1007\/s12035-017-0516-4","volume":"55","author":"KA Alkadhi","year":"2017","unstructured":"Alkadhi KA. Exercise as a positive modulator of brain function. Mol Neurobiol. 2017;55(4):3112\u201330.","journal-title":"Mol Neurobiol"},{"issue":"1","key":"1357_CR9","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3233\/JPD-171218","volume":"8","author":"S Mantri","year":"2018","unstructured":"Mantri S, Fullard ME, Duda JE, Morley JF. Physical activity in early Parkinson disease. J Parkinsons Dis. 2018;8(1):107\u201311.","journal-title":"J Parkinsons Dis"},{"issue":"3","key":"1357_CR10","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.mayocp.2017.12.015","volume":"93","author":"JE Ahlskog","year":"2018","unstructured":"Ahlskog JE. Aerobic exercise: evidence for a direct brain effect to slow Parkinson disease progression. Mayo Clin Proc. 2018;93(3):360\u201372.","journal-title":"Mayo Clin Proc"},{"issue":"12","key":"1357_CR11","doi-asserted-by":"publisher","first-page":"e0190160","DOI":"10.1371\/journal.pone.0190160","volume":"12","author":"W Zhou","year":"2017","unstructured":"Zhou W, Barkow JC, Freed CR. Running wheel exercise reduces alpha-synuclein aggregation and improves motor and cognitive function in a transgenic mouse model of Parkinson\u2019s disease. PLoS One. 2017;12(12):e0190160.","journal-title":"PLoS One"},{"issue":"7","key":"1357_CR12","doi-asserted-by":"publisher","first-page":"5639","DOI":"10.1007\/s12035-017-0775-0","volume":"55","author":"CJHM Klemann","year":"2018","unstructured":"Klemann CJHM, Xicoy H, Poelmans G, Bloem BR, Martens GJM, Visser JE. Physical exercise modulates L-DOPA-regulated molecular pathways in the MPTP mouse model of Parkinson\u2019s disease. Mol Neurobiol. 2018;55(7):5639\u201357.","journal-title":"Mol Neurobiol"},{"key":"1357_CR13","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.lfs.2018.08.045","volume":"209","author":"Y Jang","year":"2018","unstructured":"Jang Y, Kwon I, Song W, Cosio-Lima LM, Taylor S, Lee Y. Modulation of mitochondrial phenotypes by endurance exercise contributes to neuroprotection against a MPTP-induced animal model of PD. Life Sci. 2018 Aug;209:455\u201365.","journal-title":"Life Sci"},{"issue":"1","key":"1357_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.20463\/jenb.2018.0001","volume":"22","author":"YC Jang","year":"2018","unstructured":"Jang YC, Hwang DJ, Koo JH, Um HS, Lee NH, Yeom DC, et al. Association of exercise-induced autophagy upregulation and apoptosis suppression with neuroprotection against pharmacologically induced Parkinson\u2019s disease. J Exerc Nutr Biochem. 2018;22(1):1\u20138.","journal-title":"J Exerc Nutr Biochem"},{"key":"1357_CR15","first-page":"1","volume":"9","author":"J Blesa","year":"2015","unstructured":"Blesa J, Trigo-Damas I, Quiroga-Varela A, Jackson-Lewis VR. Oxidative stress and Parkinson\u2019s disease. Front Neuroanat. 2015;9:1\u20139.","journal-title":"Front Neuroanat"},{"issue":"1","key":"1357_CR16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.molbrainres.2004.09.017","volume":"134","author":"RJ Smeyne","year":"2005","unstructured":"Smeyne RJ, Jackson-Lewis V. The MPTP model of Parkinson\u2019s disease. Mol Brain Res. 2005;134(1):57\u201366.","journal-title":"Mol Brain Res"},{"key":"1357_CR17","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/j.ejmech.2017.10.050","volume":"143","author":"S Carradori","year":"2018","unstructured":"Carradori S, Ortuso F, Petzer A, Bagetta D, De Monte C, Secci D, et al. Design, synthesis and biochemical evaluation of novel multi-target inhibitors as potential anti-Parkinson agents. Eur J Med Chem. 2018;143:1543\u201352.","journal-title":"Eur J Med Chem"},{"key":"1357_CR18","volume-title":"N-Acetylcysteine for Neuroprotection in Parkinson\u2019s Disease (NAC for PD)","author":"DC Shungu","year":"2017","unstructured":"Shungu DC. Clinical Trials.gov [Internet]. N-Acetylcysteine for Neuroprotection in Parkinson\u2019s Disease (NAC for PD). 2017 [cited 2018 Mar 30]. Available from: \n                    https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT01470027?term=N-acetyl-cysteine&cond=Parkinson+Disease&rank=2\n                    \n                  ."},{"issue":"7","key":"1357_CR19","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.neuint.2009.01.013","volume":"54","author":"J Pan","year":"2009","unstructured":"Pan J, Xiao Q, Sheng CY, Hong Z, Yang HQ, Wang G, et al. Blockade of the translocation and activation of c-Jun N-terminal kinase 3 (JNK3) attenuates dopaminergic neuronal damage in mouse model of Parkinson\u2019s disease. Neurochem Int. 2009;54(7):418\u201325.","journal-title":"Neurochem Int"},{"key":"1357_CR20","doi-asserted-by":"publisher","first-page":"e142","DOI":"10.1038\/cddis.2011.17","volume":"2","author":"C Barcia","year":"2011","unstructured":"Barcia C, Ros CM, Annese V, G\u00f3mez A, Ros-Bernal F, Aguado-Yera D, et al. IFN-\u03b3 signaling, with the synergistic contribution of TNF-\u03b1, mediates cell specific microglial and astroglial activation in experimental models of Parkinson\u2019s disease. Cell Death Dis. 2011;2:e142.","journal-title":"Cell Death Dis"},{"key":"1357_CR21","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/srep00809","volume":"2","author":"C Barcia","year":"2012","unstructured":"Barcia C, Ros CM, Annese V, Carrillo-de Sauvage MA, Ros-Bernal F, G\u00f3mez A, et al. ROCK\/Cdc42-mediated microglial motility and gliapse formation lead to phagocytosis of degenerating dopaminergic neurons in vivo. Sci Rep. 2012;2:809.","journal-title":"Sci Rep"},{"issue":"1","key":"1357_CR22","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nprot.2006.342","volume":"2","author":"V Jackson-Lewis","year":"2007","unstructured":"Jackson-Lewis V, Przedborski S. Protocol for the MPTP mouse model of Parkinson\u2019s disease. Nat Protoc. 2007;2(1):141\u201351.","journal-title":"Nat Protoc"},{"key":"1357_CR23","volume-title":"The Mouse Brain in Stereotaxic Coordinates","author":"K Franklin","year":"2004","unstructured":"Franklin K, Paxinos G. The Mouse Brain in Stereotaxic Coordinates. 2nd ed; 2004.","edition":"2"},{"issue":"1","key":"1357_CR24","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.nbd.2012.05.018","volume":"48","author":"J Blesa","year":"2012","unstructured":"Blesa J, Pifl C, S\u00e1nchez-Gonz\u00e1lez MA, Juri C, Garc\u00eda-Cabezas MA, Ad\u00e1nez R, et al. The nigrostriatal system in the presymptomatic and symptomatic stages in the MPTP monkey model: a PET, histological and biochemical study. Neurobiol Dis. 2012;48(1):79\u201391.","journal-title":"Neurobiol Dis"},{"issue":"2","key":"1357_CR25","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s00429-014-0718-8","volume":"220","author":"V Annese","year":"2015","unstructured":"Annese V, Herrero MT, Di Pentima M, Gomez A, Lombardi L, Ros CM, et al. Metalloproteinase-9 contributes to inflammatory glia activation and nigro-striatal pathway degeneration in both mouse and monkey models of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism. Brain Struct Funct. 2015;220(2):703\u201327.","journal-title":"Brain Struct Funct"},{"issue":"11","key":"1357_CR26","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1038\/cdd.2013.108","volume":"20","author":"M\u00c1 Carrillo-de Sauvage","year":"2013","unstructured":"Carrillo-de Sauvage M\u00c1, Maatouk L, Arnoux I, Pasco M, Sanz Diez A, Delahaye M, et al. Potent and multiple regulatory actions of microglial glucocorticoid receptors during CNS inflammation. Cell Death Differ. 2013;20(11):1546\u201357.","journal-title":"Cell Death Differ"},{"key":"1357_CR27","unstructured":"Samson M, Porter N, Orekoya O, Hebert JR, Adams SA, Bennett CL, et al. Glial Cell Morphological and Density Changes Through the Lifespan of Rhesus Macaques. Brain Behav Immun. 2017;155(1):3\u201312."},{"key":"1357_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fncel.2016.00165","volume":"10","author":"K Tatsumi","year":"2016","unstructured":"Tatsumi K, Okuda H, Morita-Takemura S, Tanaka T, Isonishi A, Shinjo T, et al. Voluntary exercise induces astrocytic structural plasticity in the globus pallidus. Front Cell Neurosci. 2016;10:1\u201312.","journal-title":"Front Cell Neurosci"},{"key":"1357_CR29","first-page":"9349487","volume":"2017","author":"D Huang","year":"2017","unstructured":"Huang D, Xu J, Wang J, Tong J, Bai X, Li H, et al. Dynamic changes in the nigrostriatal pathway in the MPTP mouse model of Parkinson\u2019s disease. Parkinsons Dis. 2017;2017:9349487.","journal-title":"Parkinsons Dis"},{"issue":"2","key":"1357_CR30","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1159\/000071967","volume":"78","author":"C Barcia","year":"2003","unstructured":"Barcia C, Bautista V, S\u00e1nchez-Bahillo A, Fern\u00e1ndez-Villalba E, Navarro-Ruis JM, Fern\u00e1ndez Barreiro A, et al. Circadian determinations of cortisol, prolactin and melatonin in chronic methyl-phenyl-tetrahydropyridine-treated monkeys. Neuroendocrinology. 2003;78(2):118\u201328.","journal-title":"Neuroendocrinology"},{"issue":"1","key":"1357_CR31","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jneumeth.2003.10.017","volume":"134","author":"C Barcia","year":"2004","unstructured":"Barcia C, De Pablos V, Bautista-Hern\u00e1ndez V, Sanchez-Bahillo A, Fern\u00e1ndez-Barreiro A, Poza M, et al. Measurement of motor disability in MPTP-treated macaques using a telemetry system for estimating circadian motor activity. J Neurosci Methods. 2004;134(1):59\u201364.","journal-title":"J Neurosci Methods"},{"issue":"1","key":"1357_CR32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40035-015-0042-0","volume":"4","author":"Q Wang","year":"2015","unstructured":"Wang Q, Liu Y, Zhou J. Neuroinflammation in Parkinson\u2019s disease and its potential as therapeutic target. Transl Neurodegener. 2015;4(1):19.","journal-title":"Transl Neurodegener"},{"issue":"4","key":"1357_CR33","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1002\/mds.21751","volume":"23","author":"PL McGeer","year":"2008","unstructured":"McGeer PL, McGeer EG. Glial reactions in Parkinson\u2019s disease. Mov Disord. 2008;23(4):474\u201383.","journal-title":"Mov Disord"},{"issue":"1","key":"1357_CR34","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s11064-008-9656-2","volume":"34","author":"RL Miller","year":"2009","unstructured":"Miller RL, James-Kracke M, Sun GY, Sun AY. Oxidative and inflammatory pathways in parkinson\u2019s disease. Neurochem Res. 2009;34(1):55\u201365.","journal-title":"Neurochem Res"},{"key":"1357_CR35","first-page":"186","volume":"2016","author":"Y Jang","year":"1655","unstructured":"Jang Y, Koo J-H, Kwon I, Kang E-B, Um H-S, Soya H, et al. Neuroprotective effects of endurance exercise against neuroinflammation in MPTP-induced Parkinson\u2019s disease mice. Brain Res. 2016;1655:186\u201393.","journal-title":"Brain Res."},{"issue":"1","key":"1357_CR36","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/mds.23455","volume":"26","author":"GM Halliday","year":"2011","unstructured":"Halliday GM, Stevens CH. Glia: initiators and progressors of pathology in Parkinson\u2019s disease. Mov Disord. 2011;26(1):6\u201317.","journal-title":"Mov Disord"},{"issue":"7638","key":"1357_CR37","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541(7638):481\u20137.","journal-title":"Nature"},{"key":"1357_CR38","doi-asserted-by":"publisher","first-page":"102419","DOI":"10.1155\/2015\/102419","volume":"2015","author":"M Batlle","year":"2015","unstructured":"Batlle M, Ferri L, Andrade C, Ortega FJ, Vidal-Taboada JM, Pugliese M, et al. Astroglia-microglia cross talk during neurodegeneration in the rat hippocampus. Biomed Res Int. 2015;2015:102419.","journal-title":"Biomed Res Int"},{"issue":"2","key":"1357_CR39","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1152\/physrev.00011.2010","volume":"91","author":"H Kettenmann","year":"2011","unstructured":"Kettenmann H, Hanisch U-K, Noda M, Verkhratsky A. Physiology of microglia. Physiol Rev. 2011;91(2):461\u2013553.","journal-title":"Physiol Rev"},{"issue":"1","key":"1357_CR40","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00401-009-0619-8","volume":"119","author":"MV Sofroniew","year":"2010","unstructured":"Sofroniew MV, Vinters HV. Astrocytes: biology and pathology. Acta Neuropathol. 2010;119(1):7\u201335.","journal-title":"Acta Neuropathol"},{"issue":"11","key":"1357_CR41","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1007\/s00702-006-0479-5","volume":"113","author":"MM Edwards","year":"2006","unstructured":"Edwards MM, Robinson SR. TNF alpha affects the expression of GFAP and S100B: implications for Alzheimer\u2019s disease. J Neural Transm. 2006;113(11):1709\u201315.","journal-title":"J Neural Transm"},{"key":"1357_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2202-8-2","volume":"8","author":"J Steiner","year":"2007","unstructured":"Steiner J, Bernstein HG, Bielau H, Berndt A, Brisch R, Mawrin C, et al. Evidence for a wide extra-astrocytic distribution of S100B in human brain. BMC Neurosci. 2007;8:1\u201310.","journal-title":"BMC Neurosci"},{"issue":"12","key":"1357_CR43","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1007\/s00702-006-0482-x","volume":"113","author":"T Himeda","year":"2006","unstructured":"Himeda T, Watanabe Y, Tounai H, Hayakawa N, Kato H, Araki T. Time dependent alterations of co-localization of S100B and GFAP in the MPTP-treated mice. J Neural Transm. 2006;113(12):1887\u201394.","journal-title":"J Neural Transm"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-018-1357-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12974-018-1357-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-018-1357-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T19:15:27Z","timestamp":1574709327000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-018-1357-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,26]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1357"],"URL":"https:\/\/doi.org\/10.1186\/s12974-018-1357-4","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,26]]},"assertion":[{"value":"26 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal testing methods and procedures were approved by the Council of the European Community Committee (2010\/63\/EU) and by the Institutional Committee on Animal Ethics of the University of Murcia (REGA ES300305440012).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"328"}}